The latest price of Pfizer’s new drug talazoparib

Pfizer has recently made another important breakthrough in the anti-cancer field. Its new drug talazoparib (Talzenna), a poly(ADP-ribose) polymerase (PARP) inhibitor, has brought new treatment options to many breast and prostate cancer patients around the world. It has been clinically shown to be excellent in the treatment of deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. At the same time, when combined with enzalutamide, it showed significant efficacy in adult patients with HRR gene-mutated metastatic castration-resistant prostate cancer (mCRPC). At present, with the gradual promotion and application of talazoparib around the world, its selling price has attracted widespread attention in the industry.

Regarding the latest selling price of talazoparib, due to differences in economic levels, medical security policies, market supply and demand and other factors in different countries and regions, the price fluctuates to a certain extent. However, according to official information released by Pfizer Pharmaceuticals, the average global selling price of talazoparib is approximately tens of thousands of yuan per box. Specifically, overseas, the price of drugs with a specification of 0.25mg*30 pills is about more than 18,000 yuan, while the price of drugs with a specification of 1mg*30 pills is different, with a price of nearly 50,000 yuan. Although this price may put some financial pressure on some patients, considering the advantages of talazoparib in terms of efficacy and safety, as well as Pfizer's investment in R&D and production, this price is within a reasonable range. At the same time, with the continuous improvement of medical security policies and intensified market competition, the price of talazoparib is expected to gradually become more reasonable in the future. It is worth mentioning that for some patients with limited financial conditions, Lao Elements provides an affordable version. The specification of this version is 1mg*30 tablets, and the price is about 4,000, which reduces the burden on patients a lot.